Ms. Hamilton’s government experience has given her an unique understanding of the antitrust agencies’ processes and decisions which enables her to effectively counsel clients through government investigations and litigations.
Amanda Hamilton is an associate in the Washington, D.C. office of Haug Partners. Her practice concentrates on antitrust, consumer protection, and FDA law. Ms. Hamilton has particular expertise in the health care and life sciences sector, including issues involving the intersection of antitrust and intellectual property law and FDA law.
Prior to joining Haug Partners, Ms. Hamilton was a staff attorney at the Federal Trade Commission, Bureau of Competition. There, she investigated and litigated antitrust matters in a variety of industries, including pharmaceuticals, manufacturing, energy, and health care. Ms. Hamilton successful litigated several merger challenges, including Federal Trade Commission v. Ardagh Group, S.A., (alleging markets of glass containers for beer and spirits customers) and Federal Trade Commission v. Graco, Inc., (alleging market for equipment used to apply paints and other liquid finishes to a variety of manufactured goods).
Ms. Hamilton is an active member of the American Bar Association, where she is an Editor of the Health Care Chronicle for the Health Care and Pharmaceuticals Committee of the Antitrust Section. She is also an active member of the National Association of Women Lawyers ("NAWL"), where is she currently serving as Publications Chair for the 2018 Annual Meeting & Awards Luncheon and a firm representative to NAWL's Challenge Club. She has served on several of NAWL's planning committees.
In addition, Ms. Hamilton has spoken and written on antitrust issues, including drug pricing investigations and recent developments in antitrust law.
- University of Iowa (B.A. with Honors)
- University of Iowa College of Law (J.D.)
- “Patent Settlement Filing Requirements and Review Under the Medicare Prescription Drug, Improvement, and Modernization Act of 2013.” AHLA PG Briefing (June 2018)
- "Helpful Tips for Navigating an FTC Drug Pricing Investigation." FDLI's Update Magazine (Jan.-Feb. 2018)
- "What Can the FTC Do about Orphan Drug Prices?" Health Care Chronicle (Aug. 2017)
- "Creates Act of 2016: Bipartisan Bill Aimed at Curbing REMS Abuses." Haug Partners LLP (July 19, 2017)
- Moderator, “REMS: Are the Federal Agencies Signaling Increased Scrutiny?” (June 22, 2018)
- "Pharmaceutical Antitrust Enforcement Under Trump Administration," The Knowledge Group, Webinar (Sept. 20, 2017)
- "Recent Developments," American Bar Association, Antitrust Section: Health Care and Pharmaceuticals Committee (July 21, 2016)
- District of Columbia, 2006
- American Bar Association - Antitrust Section
- National Association of Women Lawyers